HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takeshi Kawamura Selected Research

Leukemia

1/2021HBO1-MLL interaction promotes AF4/ENL/P-TEFb-mediated leukemogenesis.
1/2020Activation of CpG-Rich Promoters Mediated by MLL Drives MOZ-Rearranged Leukemia.
5/2017Cooperative gene activation by AF4 and DOT1L drives MLL-rearranged leukemia.
4/2014MLL fusion proteins link transcriptional coactivators to previously active CpG-rich promoters.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takeshi Kawamura Research Topics

Disease

16Neoplasms (Cancer)
12/2024 - 07/2010
11COVID-19
05/2024 - 03/2021
8Inflammation (Inflammations)
01/2019 - 01/2002
4Infections
11/2023 - 10/2002
4Leukemia
01/2021 - 04/2014
4Lung Neoplasms (Lung Cancer)
12/2015 - 04/2010
3Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
01/2023 - 01/2005
3Proteinuria
07/2010 - 01/2005
2Fever (Fevers)
01/2023 - 01/2022
2Chronic Kidney Failure (Chronic Renal Failure)
01/2023 - 02/2009
2Arthralgia (Joint Pain)
01/2023 - 01/2022
2Carcinoma (Carcinomatosis)
01/2022 - 01/2021
2Wilms Tumor (Wilm's Tumor)
11/2021 - 11/2013
2Thrombosis (Thrombus)
03/2020 - 06/2016
2Neutropenia
01/2020 - 01/2019
2Diabetic Nephropathies (Diabetic Nephropathy)
06/2019 - 07/2018
2Hypertension (High Blood Pressure)
06/2019 - 07/2018
2Body Weight (Weight, Body)
06/2019 - 05/2015
2Diabetes Mellitus
06/2019 - 07/2018
2Liver Failure
01/2019 - 04/2012
2Adenocarcinoma of Lung
12/2015 - 04/2010
2Liposarcoma
08/2011 - 01/2011
2Ascites
08/2011 - 10/2010
1Renal Cell Carcinoma (Grawitz Tumor)
12/2024
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2024
1Communicable Diseases (Infectious Diseases)
05/2024
1Hypophosphatemia
01/2023
1Chronic Disease (Chronic Diseases)
01/2023
1Headache (Headaches)
01/2023
1Diarrhea
01/2023
1Genomic Instability
11/2022
1Virus Diseases (Viral Diseases)
06/2021
1Hypoxia (Hypoxemia)
01/2021
1Type 2 von Willebrand Disease
03/2020
1Immunoglobulin G4-Related Disease
10/2019

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
02/2024 - 08/2007
8Immunoglobulin G (IgG)IBA
01/2023 - 10/2019
5Immunoglobulin M (IgM)IBA
05/2022 - 01/2005
4Messenger RNA (mRNA)IBA
11/2023 - 02/2010
4AntibodiesIBA
11/2023 - 01/2019
4Neutralizing AntibodiesIBA
11/2023 - 01/2016
3VaccinesIBA
05/2024 - 03/2022
3BNT162 VaccineIBA
01/2023 - 11/2022
3Rituximab (Mabthera)FDA Link
01/2019 - 12/2006
3EnzymesIBA
08/2007 - 01/2002
2Peptides (Polypeptides)IBA
12/2024 - 12/2015
2AntigensIBA
11/2023 - 01/2019
2silicon phthalocyanineIBA
12/2022 - 01/2022
2Immunoglobulin A (IgA)IBA
05/2022 - 02/2022
2Viral ProteinsIBA
02/2022 - 06/2021
2LigandsIBA
01/2016 - 06/2012
2ParaffinIBA
12/2015 - 04/2010
2Formaldehyde (Formol)FDA Link
12/2015 - 04/2010
2Cisplatin (Platino)FDA LinkGeneric
08/2011 - 10/2010
1NucleotidesIBA
12/2024
1Cancer VaccinesIBA
12/2024
1HLA Antigens (Human Leukocyte Antigens)IBA
12/2024
1Biotin (Vitamin H)FDA Link
02/2024
1StreptavidinIBA
02/2024
1mRNA VaccinesIBA
11/2023
12019-nCoV Vaccine mRNA-1273IBA
01/2023
1Phosphorus (Red Phosphorus)IBA
01/2023
1Cys-ZHER2-342 affibodyIBA
12/2022
1DNA (Deoxyribonucleic Acid)IBA
11/2022
1NucleoproteinsIBA
05/2022
1Nucleocapsid ProteinsIBA
02/2022
1human ERBB2 proteinIBA
01/2022
1Analgesics (Analgesic Drugs)IBA
01/2022
1Immunoconjugates (Immunoconjugate)IBA
01/2022
1AntipyreticsIBA
01/2022
1iminobiotinIBA
01/2022
1IntegrinsIBA
01/2022
1RNA (Ribonucleic Acid)IBA
11/2021
16-methyladenineIBA
11/2021
1N-methyladenosineIBA
11/2021
1MethyltransferasesIBA
06/2021
1ChromatinIBA
06/2021
1CohesinsIBA
06/2021
1OligonucleotidesIBA
05/2021
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
05/2021
1A-Form DNA (A-DNA)IBA
05/2021
1Immunologic Factors (Immunomodulators)IBA
01/2021
1pembrolizumabIBA
01/2021
1Oncogene Proteins (Oncogene Protein)IBA
01/2021
1Translationally-Controlled 1 Tumor ProteinIBA
01/2021
1Thromboplastin (Tissue Factor)IBA
03/2020
1von Willebrand FactorIBA
03/2020
1CollagenIBA
03/2020
1Factor VIII (Coagulation Factor VIII)IBA
03/2020
1FibrinIBA
03/2020
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2020
1Uric Acid (Urate)IBA
06/2019

Therapy/Procedure

9Kidney Transplantation
01/2023 - 01/2003
9Transplantation
01/2023 - 01/2005
8Therapeutics
02/2024 - 01/2003
4Lasers (Laser)
12/2015 - 08/2007
3Drug Therapy (Chemotherapy)
01/2011 - 03/2002
2Immunotherapy
12/2024 - 01/2021
2Hepatectomy
01/2019 - 04/2012
2Precision Medicine
01/2019 - 08/2007